Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated June 26, 2026, except for the effects of the reverse stock split discussed in Note 13, as to which the date is October 5, 2026, with respect to the financial statements of TRex Bio, Inc., included herein, and to the reference to our firm under the heading "Experts" in the prospectus.

/s/ KPMG LLP

San Francisco, California
October 5, 2026